Marc Cluzel
Chairman at MORPHOSYS AG
Net worth: 618 710 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Picard | M | - |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | 21 years |
| Krisja Vermeylen | F | 62 | 7 years | |
| Julia Neugebauer | M | - | 18 years | |
| Gerard A. Tardy | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Luisa Ciccarelli | F | - | 3 years | |
| Daniel Palmacci | M | - | 4 years | |
| Günter Wellnhofer | M | - | 30 years | |
| Michel Maurice Lazdunski | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Sharon Curran | F | 56 | 5 years | |
| Thomas Biegi | M | - | 4 years | |
| Lucinda Crabtree | M | 45 | 1 years | |
| Michael Brosnan | M | 69 | 6 years | |
| Isabelle Degbegni | F | - | - | |
| Philippe Guy | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | 16 years |
| Tim Demuth | M | 50 | 2 years | |
| Ann Merchant | F | 59 | 6 years | |
| Robert Mayer | M | - | 3 years | |
| Foong Mei Hui | F | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Jean-Paul Kress | M | 59 | 5 years | |
| Robert Gan | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Elmar Schnee | M | 65 |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | 10 years |
| Ralf Ostendorp | M | - | 25 years | |
| Klaus de Wall | M | - | 19 years | |
| Barbara Krebs-Pohl | M | - | 26 years | |
| Xavier Champavere | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Charlotte Lohmann | F | 54 | 12 years | |
| Olivier Antoine M. Charmeil | M | 59 | 18 years | |
| Andrew Cheng | M | 57 | 2 years | |
| Laurent J. Degryse | M | 57 |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| George Golumbeski | M | 67 | 6 years | |
| Christophe Polini | M | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | - |
| Eamonn Nolan | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Serge Weinberg | M | 73 | - | |
| Jean-René Fourtou | M | 84 | - | |
| Philippe Peyre | M | 73 | - | |
| Klaus Kühn | M | 72 | 3 years | |
| Frank Morich | M | 69 | 5 years | |
| Robert Castaigne | M | 78 | 18 years | |
| Arthur Charles V. Wellesley | M | 78 | 12 years | |
| Claudie Haigneré | M | 67 | 12 years | |
| Claudia Gutjahr-Löser | M | - | - | |
| Gerald Heinz Möller | M | 80 | 19 years | |
| Anke Linnartz | F | 54 | - | |
| Thierry Vernier | M | - | - | |
| Christopher Viehbacher | M | 64 | 6 years | |
| Markus Enzelberger | M | 55 | 18 years | |
| Ji Zhang | M | - | - | |
| Alexandra Goller | F | - | - | |
| Ludger Langer | M | - | - | |
| Philippe Pierre Goupit | M | - | 20 years | |
| Malte Peters | M | 61 | 5 years | |
| Jean Zetlaoui | M | - | 19 years | |
| Roland Wandeler | M | 51 | 1 years | |
| Klaus Pohle | M | 86 | 12 years | |
| Muriel Bardet | F | - | 16 years | |
| Jürgen Dormann | M | 84 | - | |
| Karin Eastham | F | 74 | 5 years | |
| Walter Blättler | M | 75 | 8 years | |
| Gérard van Kemmel | M | 84 | - | |
| Uwe Bicker | M | 78 | - | |
| Metin Colpan | M | 69 | 8 years | |
| Thierry Desmarest | M | 78 | 14 years | |
| Simon Moroney | M | 65 | 27 years | |
| Geoffrey Nicholas Vernon | M | 72 | 16 years | |
| Daniel Camus | M | 70 | 12 years | |
| Jürgen Drews | M | 91 | 14 years | |
| Wendy Johnson | F | 72 | 7 years | |
| Dominique Laymand | F | 69 |
Université de Montpellier
| 3 years |
| Dario Eklund | M | 56 | 2 years | |
| Pierre Brondeau | M | 66 |
Université de Montpellier
| 1 years |
| Emmanuel Dulac | M | 55 | 9 years | |
| Christian Mulliez | M | 63 | 15 years | |
| Herve Richert | M | - |
Université de Montpellier
| 3 years |
| Nathalie Therrien | F | 56 | 3 years | |
| Léopold Bertea | M | 60 | 6 years | |
| Frédéric Besème | M | 67 |
Université de Montpellier
| 3 years |
| David L. Guy | M | 61 | 6 years | |
| Christopher Hwang | M | 61 | 24 years | |
| Robert Sebbag | M | 73 | 10 years | |
| Gérard Le Fur | M | 73 | 22 years | |
| Alain Herrera | M | 74 | 10 years | |
| Bruno Roger | M | 90 | 15 years | |
| Marie-Claire Simone Daveu | F | 53 | - | |
| Jean-François Dehecq | M | 84 | 11 years | |
| Gunter Thielen | M | 81 | 1 years | |
| Jean-Marc Bruel | M | - | 6 years | |
| Jean-Claude Leroy | M | - | - | |
| Philippe Roger Guitard | M | 63 |
Université de Montpellier
| 4 years |
| Igor Landau | M | 78 | 11 years | |
| Pierre Chancel | M | 67 | - | |
| Laure Thibaud | F | - | - | |
| Riccardo Perfetti | M | 64 | 11 years | |
| François Beloeuvre | M | - | - | |
| Thierry Bourquin | M | - | - | |
| Robert DeBerardine | M | - | - | |
| Heraldo Carvalho Marchezini | M | - | 4 years | |
| Pascal J. Druzgala | M | 69 |
Université de Montpellier
| 3 years |
| Sonia Serfaty | F | - |
Université de Montpellier
| 3 years |
| Jérôme d’Enfert | M | - |
Université de Montpellier
| 3 years |
| Jean-Pierre Lehner | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 51 | 51.00% |
| Germany | 39 | 39.00% |
| Singapore | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marc Cluzel
- Personal Network